Purchases and Sales Made in Q4 2022 in Sarepta Therapeutics, Inc. (SRPT)
This table provides information about the institutional ownership of Sarepta Therapeutics, Inc. (SRPT) during Q4 2022. The information is specifically focused on institutions that hold shares of Sarepta Therapeutics, Inc..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Feb 13, 2023
Q4 2022
|
Sands Capital Management, LLC
Arlington, VA |
SELL
|
- |
-331K- 13.33% |
$33.4M - $43.7M
|
2.15M
$41.4M
|
|
Feb 14, 2023
Q4 2022
|
Price T Rowe Associates Inc
Baltimore, MD |
SELL
|
- |
-382K- 31.36% |
$38.5M - $50.5M
|
837K
$16.1M
|
|
Jan 12, 2023
Q4 2022
|
Assenagon Asset Management S.A.
|
SELL
|
- |
-396K- 35.12% |
$40M - $52.4M
|
733K
$14.1M
|
|
Feb 14, 2023
Q4 2022
|
Janus Henderson Group PLC
London, X0 |
SELL
|
- |
-450K- 6.95% |
$45.4M - $59.5M
|
6.03M
$116M
|
|
Feb 13, 2023
Q4 2022
|
Alkeon Capital Management LLC
New York, NY |
SELL
|
- |
-558K- 45.3% |
$56.3M - $73.7M
|
674K
$13M
|